Literature DB >> 7841045

Selective photodynamic inactivation of a multidrug transporter by a cationic photosensitising agent.

D Kessel1, K Woodburn.   

Abstract

We have characterised sites of photodamage catalysed by the cationic photosensitiser tetrabromorhodamine 123, using P388 murine leukaemia cells and a subline (P388/ADR) which has a multidrug resistance phenotype and hyperexpresses mdr1 mRNA for P-glycoprotein. Fluorescence emission spectra were consistent with sensitiser localisation in hydrophobic regions of the P388 cell, and in more aqueous loci in P388/ADR. Subsequent irradiation resulted in photodamage to the P388 cells, resulting in loss of viability. In contrast, P388/ADR cells were unaffected except for an irreversible inhibition of P-glycoprotein, leading to enhanced accumulation of daunorubicin and rhodamine 123 and a corresponding increase in daunorubicin cytotoxicity. These results are consistent with the premise that substrates for P-glycoprotein are confined to membrane loci associated with the transporter, and indicate a very limited migration of cytotoxic photo-products in a cellular environment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7841045      PMCID: PMC2033570          DOI: 10.1038/bjc.1995.61

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

Review 1.  Photochemotherapy of cancer: experimental research.

Authors:  J Moan; K Berg
Journal:  Photochem Photobiol       Date:  1992-06       Impact factor: 3.421

2.  Exploring multidrug resistance using rhodamine 123.

Authors:  D Kessel
Journal:  Cancer Commun       Date:  1989

Review 3.  How does photodynamic therapy work?

Authors:  B W Henderson; T J Dougherty
Journal:  Photochem Photobiol       Date:  1992-01       Impact factor: 3.421

4.  Subcellular localization of hematoporphyrin derivative in bladder tumor cells in culture.

Authors:  J R Shulok; M H Wade; C W Lin
Journal:  Photochem Photobiol       Date:  1990-04       Impact factor: 3.421

5.  The effect of a chalcogenapyrylium dye with and without photolysis on mitochondrial function in normal and tumor cells.

Authors:  D L Walstad; J T Brown; S K Powers
Journal:  Photochem Photobiol       Date:  1989-03       Impact factor: 3.421

6.  Rhodamine dyes as potential agents for photochemotherapy of cancer in human bladder carcinoma cells.

Authors:  C R Shea; N Chen; J Wimberly; T Hasan
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

7.  Photosensitization, uptake, and retention of phenoxazine Nile blue derivatives in human bladder carcinoma cells.

Authors:  C W Lin; J R Shulok; Y K Wong; C F Schanbacher; L Cincotta; J W Foley
Journal:  Cancer Res       Date:  1991-02-15       Impact factor: 12.701

Review 8.  Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and other factors.

Authors:  W T Beck
Journal:  Cancer Treat Rev       Date:  1990-12       Impact factor: 12.111

9.  Characterization of multidrug resistance by fluorescent dyes.

Authors:  D Kessel; W T Beck; D Kukuruga; V Schulz
Journal:  Cancer Res       Date:  1991-09-01       Impact factor: 12.701

10.  The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen.

Authors:  J Moan; K Berg
Journal:  Photochem Photobiol       Date:  1991-04       Impact factor: 3.421

View more
  3 in total

1.  Selective photodepletion of malignant T cells in extracorporeal photopheresis with selenorhodamine photosensitizers.

Authors:  Zachariah A McIver; Mark W Kryman; Young Choi; Benjamin N Coe; Gregory A Schamerhorn; Michelle K Linder; Kellie S Davies; Jacqueline E Hill; Geri A Sawada; Jason M Grayson; Michael R Detty
Journal:  Bioorg Med Chem       Date:  2016-06-02       Impact factor: 3.641

Review 2.  Multifunctional Nanoplatforms as a Novel Effective Approach in Photodynamic Therapy and Chemotherapy, to Overcome Multidrug Resistance in Cancer.

Authors:  Martin Majerník; Rastislav Jendželovský; Jana Vargová; Zuzana Jendželovská; Peter Fedoročko
Journal:  Pharmaceutics       Date:  2022-05-17       Impact factor: 6.525

3.  Selenorhodamine photosensitizers for photodynamic therapy of P-glycoprotein-expressing cancer cells.

Authors:  Jacqueline E Hill; Michelle K Linder; Kellie S Davies; Geri A Sawada; Janet Morgan; Tymish Y Ohulchanskyy; Michael R Detty
Journal:  J Med Chem       Date:  2014-10-01       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.